High- versus lower-intensity supervised exercise after cancer treatment

Evidence label: Positive randomized fitness and fatigue evidence; intensity advantage uncertain · Clinical goal: improve fitness and fatigue after primary cancer treatment

Evidence at a glance

Population: 277 survivors of several cancer types, assessed four to six weeks after completing primary treatment including chemotherapy.
Intervention: 12 weeks of supervised high-intensity or low-to-moderate-intensity resistance and endurance training, compared with a wait-list.
Result: both intensities improved aerobic fitness and fatigue; the difference between intensities was not statistically significant.

What was studied

REACT randomized 91 participants to high-intensity exercise, 95 to low-to-moderate intensity and 91 to a wait-list. Programs used similar exercise types, frequency and duration and differed mainly in intensity. Primary outcomes were peak oxygen uptake, grip and chair-stand strength, and multidimensional fatigue.

What the evidence shows

Compared with wait-list, peak oxygen uptake improved by 2.2 mL/kg/min (95% CI 1.2 to 3.1) with high intensity and 1.3 (95% CI 0.3 to 2.3) with lower intensity. The 0.9-point difference between exercise intensities was not statistically significant (P=.08). Both programs reduced general and physical fatigue; grip and chair-stand outcomes did not differ.

This supports supervised post-treatment training without proving that everyone needs high intensity. The outcomes were recovery and symptoms, not recurrence or survival.

Limits and uncertainty

Only 37% of eligible patients enrolled, about 10% dropped out and cancer types were mixed. Participants had completed primary treatment and results may not apply during active therapy or to people with major limitations. Wait-list comparison was not blinded.

Safety and practical context

Intensity should follow current cardiopulmonary status, anemia, neuropathy, surgical recovery and bone health. High-intensity work is not automatically better and may be inappropriate without assessment. Chest pain, syncope, acute infection or new focal bone pain need evaluation.

Questions for the care team

Am I ready for supervised training four to six weeks after treatment, or do I need more recovery first?
Would lower intensity provide most of the benefit with fewer barriers?
How will fitness and fatigue be reassessed before increasing intensity?

Sources

Literature searched: October 22, 2026 · Record appraised: October 22, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.